Sugandha Dureja, MD, FEBNM, nuclear medicine expert and founder of CNETS India, was the featured guest for the Carcinoid Cancer Foundation’s Luncheon with the Experts Facebook Live program on August 12, 2021. Dr. Dureja is among the first Indian specialists with international training in peptide receptor radionuclide therapy (PRRT) in Bad Berka, Germany. Her mentor in Bad Berka was Prof. Richard Baum, one of the world’s leaders in theranostics, the emerging field arising from nuclear medicine in which drugs and/or techniques are used to diagnose and treat medical conditions. Dr. Dureja has extensive experience in Gallium 68 DOTANOC PET/CT imaging, PRRT, and the latest Alpha PRRT and Y90 therapies for neuroendocrine tumor patients. She has a special interest and experience in radionuclide therapy for the management of neuroendocrine and prostate cancers.